Shalby cash flow

Latest FY26

Cash from operations: −₹0.0cr−₹4.3 cr in FY25
Capital spending: ₹149cr+108.6% on FY25
Free cash flow: −₹149cr−₹75.8 cr in FY25
Cash from financing: ₹84.4cr+77.4% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	70.0	65.8	52.2	38.8
	—	39.0	38.7	13.0	9.1
	—	−2.2	−7.2	−5.0	−7.9
	—	0.0	0.0	1.0	0.8
	—	0.0	0.0	−0.1	1.0
	—	−21.4	−4.5	0.0	−1.8
	—	−7.5	−8.0	−8.6	0.0
	—	0.0	0.0	−1.1	0.0
	—	−60.6	−84.0	−47.8	−64.3
	—	−56.3	−31.1	−32.9	−5.5
	—	2.2	1.7	−3.7	9.2
	—	0.6	3.8	−3.8	−3.6
	—	2.4	−13.2	0.7	−4.8
	—	−0.4	1.6	−3.9	5.5
	—	8.7	−8.2	−31.1	17.3
	—	2.5	0.1	−0.1	0.6
	—	0.0	−0.1	−9.0	−0.1
	—	1.1	−1.5	−9.4	−1.8
	—	−1.4	−1.7	−1.4	1.1
	—	0.0	2.0	2.4	0.5
	—	2.6	0.0	0.0	0.0
Cash from operating activities
	57.6	60.6	55.7	128	102
	—	−20.7	−45.8	−88.5	−5.9
	—	39.9	9.9	39.7	96.2
	—	39.9	14.2	20.1	28.4
	—	−0.0	−4.3	19.6	67.8
Cash from investing activities
	—	149	71.4	47.1	18.5
	—	3.8	1.4	1.9	0.7
	—	481	525	0.0	0.0
	—	518	519	0.0	0.0
	—	0.0	0.0	−4.4	465
	—	0.0	0.0	0.0	414
	—	1.7	7.7	5.1	8.5
	—	9.0	32.2	73.7	0.0
	—	−97.3	−35.6	38.1	−61.1
Cash from financing activities
	—	0.0	0.1	0.0	0.0
	—	0.0	0.0	0.1	0.0
	—	0.0	0.0	206	7.5
	—	154	152	89.7	26.9
	—	41.3	39.3	0.0	40.3
	—	25.0	17.6	0.0	0.0
	—	—	—	8.9	11.0
	—	35.1	34.7	12.9	7.4
	—	0.0	13.0	13.0	10.8
	—	31.6	0.1	0.1	0.1
	—	84.4	47.6	−151	−50.0
	—	−12.9	7.6	−93.0	−43.3
	—	−12.9	7.6	−93.0	−43.3
	—	—	—	27.2	12.2
Reference items
	143	143	133	177	137
	12.1%	12.5%	12.2%	19.0%	17.0%
	−149	−149	−75.8	−27.5	49.3
	—	−71.2	2.2	93.1	—
	−₹13.86	−₹13.86	−₹7.05	−₹2.56	₹4.58
	—	−0.00×	−2.26×	0.23×	1.00×
	—	39.9	14.2	20.1	28.4
	—	35.1	34.7	12.9	7.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHALBY₹121.96

Shalby Limited

· Pharma & Health

₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,311 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	38.8	52.2	65.8	70.0	—
+ Finance Costs	9.1	13.0	38.7	39.0	—
+ Interest Income	-7.9	-5.0	-7.2	-2.2	—
+ Share-based Payments	0.8	1.0	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	1.0	-0.1	0.0	0.0	—
+ Other Non-cash Items	-1.8	0.0	-4.5	-21.4	—
+ Other — Cash Effects are Investing / Financing	0.0	-8.6	-8.0	-7.5	—
+ Other Reconciling Items	0.0	-1.1	0.0	0.0	—
Changes in Working Capital
+ Inventories	-64.3	-47.8	-84.0	-60.6	—
+ Trade Receivables — Current	-5.5	-32.9	-31.1	-56.3	—
+ Other Financial Assets — Current	9.2	-3.7	1.7	2.2	—
+ Other Financial Assets — Non-current	-3.6	-3.8	3.8	0.6	—
+ Other Current Assets	-4.8	0.7	-13.2	2.4	—
+ Other Non-current Assets	5.5	-3.9	1.6	-0.4	—
+ Trade Payables — Current	17.3	-31.1	-8.2	8.7	—
+ Other Financial Liabilities — Current	0.6	-0.1	0.1	2.5	—
+ Other Financial Liabilities — Non-current	-0.1	-9.0	-0.1	0.0	—
+ Other Current Liabilities	-1.8	-9.4	-1.5	1.1	—
+ Other Non-current Liabilities	1.1	-1.4	-1.7	-1.4	—
+ Provisions — Current	0.5	2.4	2.0	0.0	—
+ Provisions — Non-current	0.0	0.0	0.0	2.6	—
Cash from Operating Activities
Profit Before Tax (per I/S)	102.0	128.2	55.7	60.6	57.6
+ Total Adjustments (incl. Working Capital)	-5.9	-88.5	-45.8	-20.7	—
Cash from Operations (pre-tax)	96.2	39.7	9.9	39.9	—
+ Income Taxes Paid	28.4	20.1	14.2	39.9	—
Cash from Operating Activities	67.8	19.6	-4.3	-0.0	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	18.5	47.1	71.4	149.0	—
+ Disp of Fixed Assets	0.7	1.9	1.4	3.8	—
+ Acq of Investment Property	0.0	0.0	524.9	481.0	—
+ Disp of Investment Property	0.0	0.0	519.3	518.2	—
+ Acq of Other Long-term Assets	465.3	-4.4	0.0	0.0	—
+ Disp of Other Long-term Assets	413.5	0.0	0.0	0.0	—
+ Interest Received — Investing	8.5	5.1	7.7	1.7	—
+ Other Inflows / (Outflows) — Investing	0.0	73.7	32.2	9.0	—
Cash from Investing Activities	-61.1	38.1	-35.6	-97.3	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	0.1	0.0	—
+ Proceeds from Exercise of Stock Options	0.0	0.1	0.0	0.0	—
+ Buyback / Redemption of Own Shares	7.5	205.9	0.0	0.0	—
+ Proceeds from Borrowings	26.9	89.7	152.1	154.2	—
+ Repayment of Borrowings	40.3	0.0	39.3	41.3	—
+ Payment of Lease Liabilities	0.0	0.0	17.6	25.0	—
+ Payment of Finance Lease Liabilities	11.0	8.9	—	—	—
+ Interest Paid	7.4	12.9	34.7	35.1	—
+ Dividends Paid	10.8	13.0	13.0	0.0	—
+ Other Inflows / (Outflows) — Financing	0.1	0.1	0.1	31.6	—
Cash from Financing Activities	-50.0	-150.7	47.6	84.4	—
Net Changes in Cash (pre-FX)	-43.3	-93.0	7.6	-12.9	—
Net Changes in Cash	-43.3	-93.0	7.6	-12.9	—
Closing Cash	12.2	27.2	—	—	—
Reference Items
EBITDA	136.7	177.0	132.6	142.8	142.8
EBITDA Margin %	16.99	18.96	12.20	12.51	12.14
Free Cash Flow (CFO − Capex)	49.3	-27.5	-75.8	-149.1	-149.1
Free Cash Flow to Equity	—	93.1	2.2	-71.2	—
Free Cash Flow per Basic Share	4.58	-2.56	-7.05	-13.86	-13.86
Cash Flow to Net Income	1.00	0.23	-2.26	-0.00	—
Cash Paid for Taxes	28.4	20.1	14.2	39.9	—
Cash Paid for Interest	7.4	12.9	34.7	35.1	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.